bpc-157 oral vs injection dosing Peptide Oral: Which Route Actually Works? bpc-157 oral vs injectable comparison

Researched effects In a diet-induced-obese mouse study (Neelakantan et al., Biochemical Pharmacology, 2018), subcutaneous 5-Amino-1MQ (20 mg/kg, three times daily, roughly 11 days) produced about 5.1% body-weight loss versus continued weight gain in untreated controls, roughly 35% less epididymal white fat mass, smaller adipocytes, lower plasma cholesterol, and improved glucose tolerance, with no reported change in food intake and no observed adverse effects in the mice

But honestly, the short answer doesn't do justice to the science behind it or the potential consequences of getting it wrong

The empty B12 vial can also go into the sharps bin

BPC-157 is a stable gastric pentadecapeptide originally derived from human gastric juice, while TB-500 is a synthetic peptid

This mechanism is also the source of cancer-related concerns (more below)

But they have their fair share of cons